Barclays
CPIX icon

Barclays’s Cumberland Pharmaceuticals CPIX Stock Holding History

Barclays’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3.09K Buy
395
+347
+723% +$2.52K ﹤0.01% 4929
2026
Q2 		$311 Buy
+48
New +$230 ﹤0.01% 5063
2025
Q3 		– Sell
-2
Closed -$7 – 5523
2025
Q2 		$7 Buy
+2
New +$9 ﹤0.01% 5161
2020
Q3 		– Sell
-22
Closed – – 5261
2020
Q2 		$0 Buy
+22
New +$80 ﹤0.01% 5653
2020
Q1 		– Sell
-3
Closed – – 6175
2019
Q4 		$0 Sell
3
-82
-96% -$433 ﹤0.01% 6401
2019
Q3 		$1K Buy
+85
New +$473 ﹤0.01% 6579
2013
Q3 		– Sell
-10,761
Closed -$55K – 7429
2013
Q2 		$55K Buy
+10,761
New +$53.5K ﹤0.01% 6243

Other funds holding CPIX

Diversified Trust
Diversified Trust Memphis, Tennessee $4.69B AUM 22.36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Bailard
Bailard Foster City, California $4.94B AUM 25.15% 1-Year Est. Return
Lantern Wealth Advisors
Lantern Wealth Advisors Melville, New York $232M AUM 16.88% 1-Year Est. Return
Capital Advisors Ltd
Capital Advisors Ltd Shaker Heights, Ohio $987M AUM 13.52% 1-Year Est. Return

Barclays's CPIX Position: Q3 2026 in Review

Barclays increased its Cumberland Pharmaceuticals (CPIX) stake by 723% in Q3 2026, buying an estimated $2.52K and bringing the position to 395 shares worth $3.09K. The position accounts for ﹤0.01% of the portfolio, ranked #4929.

Barclays first reported a position in CPIX in Q2 2013 and has held it in 7 quarters since. The position peaked at $55K in Q2 2013. 8 funds tracked by Wall St. Rank hold CPIX as of Q3 2026.

  • Barclays held 395 shares of Cumberland Pharmaceuticals worth $3.09K as of Q3 2026.
  • Barclays bought 347 Cumberland Pharmaceuticals shares in Q3 2026, an estimated $2.52K.
  • Cumberland Pharmaceuticals made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #4929 holding.
  • Barclays first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 7 quarters since.
  • Barclays's Cumberland Pharmaceuticals position peaked at $55K in Q2 2013.
  • 8 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.